معرفی
Michael Liptay is a Professor in the Department of Cardiovascular and Thoracic Surgery at Rush University, Rush Medical College. His research focuses on thoracic surgery, lung cancer outcomes, and biomarker development for early cancer detection. He has authored over 200 publications, primarily investigating surgical prognostication, biomarker panels for pulmonary nodules, and the impact of preoperative factors on postoperative survival.
Key research interests include non-small cell lung cancer (NSCLC) prognosis, surgical risk stratification, and the role of IGF-pathway biomarkers. Collaborations with institutions like the Society of Thoracic Surgeons highlight his contributions to clinical database analysis and evidence-based practice.
His work emphasizes translational research, bridging molecular biology and clinical outcomes, particularly in developing diagnostic tools for actionable pulmonary lesions. Notable projects include the development of autoantibody panels and prolonged air leak scoring systems to improve surgical decision-making.
